5,532 reports of this reaction
1.5% of all LEVONORGESTREL reports
#18 most reported adverse reaction
COMPLICATION OF DEVICE INSERTION is the #18 most commonly reported adverse reaction for LEVONORGESTREL, manufactured by Bayer HealthCare Pharmaceuticals Inc.. There are 5,532 FDA adverse event reports linking LEVONORGESTREL to COMPLICATION OF DEVICE INSERTION. This represents approximately 1.5% of all 357,584 adverse event reports for this drug.
Patients taking LEVONORGESTREL who experience complication of device insertion should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COMPLICATION OF DEVICE INSERTION is a less commonly reported adverse event for LEVONORGESTREL, but still significant enough to appear in the safety profile.
In addition to complication of device insertion, the following adverse reactions have been reported for LEVONORGESTREL:
The following drugs have also been linked to complication of device insertion in FDA adverse event reports:
COMPLICATION OF DEVICE INSERTION has been reported as an adverse event in 5,532 FDA reports for LEVONORGESTREL. This does not prove causation, but indicates an association observed in post-market surveillance data.
COMPLICATION OF DEVICE INSERTION accounts for approximately 1.5% of all adverse event reports for LEVONORGESTREL, making it a notable side effect.
If you experience complication of device insertion while taking LEVONORGESTREL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.